We bought the seven best-selling nattokinase supplements, read every facts panel, and pulled the research. Then we scored each one. Most cleared one of our three tests. A few cleared none. Only one cleared all three.
Heart attacks and strokes are linked to more than 17 million deaths every year, and arterial plaque is the quiet driver behind them. It builds slowly: the artery wall gets irritated, cholesterol deposits, fibrin locks the buildup in place, and the channel your blood flows through narrows over time.
For a nattokinase formula to support healthier arteries, three things decide whether it works.
1) Dose. The most-cited human study, Chen 2022 (Frontiers in Cardiovascular Medicine, 1,062 participants, 12 months), found meaningful reductions in arterial plaque, blood pressure, and cholesterol at roughly 10,000 FU/day. At about 3,600 FU/day the benefit largely disappeared, yet most products on the shelf sit at 2,000.
2) Coating. Nattokinase is an enzyme that stomach acid degrades before it reaches the blood unless the capsule is enteric-coated. A big number on the label means nothing if the enzyme never survives the trip.
3) Co-factors. The research rarely studies nattokinase alone, so compounds like CoQ10, bromelain, turmeric, ginger, olive leaf, and white willow bark work alongside it. An enzyme delivered by itself is doing half the work.

Hale Heart was the only product we tested that cleared all three criteria: a clinical-range dose, enteric coating, and the full stack of cardiovascular co-factors used in supporting research. The 10,000 FU dose lands in the same range the clinical studies used to demonstrate reductions in arterial plaque, blood pressure, and cholesterol — and the enteric coating is built to get that enzyme past stomach acid intact. The only product on this list at the clinical dose with coating and the full co-factor stack.

The most concentrated single-capsule option we tested, but 4,000 FU still falls below the clinical-range dose. It's a clean, single-ingredient enzyme with no supporting co-factor stack, and the label doesn't specify enteric coating — so there's no stated protection against stomach-acid degradation. Arthur Andrew is a respected manufacturer, but anyone targeting the clinical dose would need three capsules a day and would still be missing the co-factors.

Luma Nutrition earns its #3 ranking on the strength of its 90-day guarantee, veteran-owned manufacturing credentials, and clean label. But it's a single-ingredient enzyme with no co-factor support, the label doesn't disclose enteric coating, and the 4,000 FU dose is still well below what the clinical research used. On top of that, independent potency testing by SORA Labs (an ISO 17025-accredited laboratory) in 2026 flagged the product as falling below the assay's linear measurement range — meaning actual fibrinolytic activity was less than 2,660 FU per serving against the 4,000 FU label claim. A label that does not match the lab is a serious concern in a category where dose is everything.

Natocore deserves credit for the two criteria it clears: a seven-ingredient co-factor stack and enteric-coated delivery. Where it falls down is dose. The per-softgel dose is the lowest on this list at ~1,333 FU, requiring eight softgels daily to approach the clinical range. The 30-day guarantee is the shortest we tested. And the brand provides limited visibility into raw material sourcing — no publicly available supplier certifications and no country-of-origin disclosures for the nattokinase extract or co-factor ingredients.

A modest improvement over the standard pharmacy-aisle 2,000 FU products, but it clears none of the three criteria cleanly: the dose is nowhere near the clinical range, there are no co-factors, and the label doesn't disclose enteric coating. Decent option if you specifically want a stand-alone enzyme and you are prepared to stack it with a separate cardiovascular formula yourself.

Solid manufacturer with a strong reputation, but it clears only the brand-trust test, not the formulation ones. The dose is identical to the pharmacy generics, there are no co-factors, and the label doesn't disclose enteric coating. To approach the clinical dose, a user would need five capsules per day — at which point the cost-per-month exceeds most premium products that get them there in one serving.

The most-purchased category by sheer shelf presence, and also the lowest performing — it clears none of the three criteria. Reader feedback online is consistent: months of use, no measurable change. This is the bottle most people start with, get nothing from, and use to conclude that nattokinase does not work. The compound is not the problem. The dose is.
See the studies, the dosing rationale, and the complete ingredient panel before you buy.
View Hale Heart →If you have been taking a 2,000 FU nattokinase supplement for months and waiting for something to change in your bloodwork, the most likely explanation is not that nattokinase does not work. It is that the dose in the bottle is roughly a fifth of the dose the research used.
The supplement aisle is full of nattokinase products that print impressive-sounding numbers on the front of the bottle and quietly deliver a fraction of the dose on the back. Read the supplement facts panel on whatever you are taking. Check three things: the per-serving FU total, whether it says enteric-coated, and whether there are any cardiovascular co-factors at all. If the dose is below 8,000 FU, you are not taking the dose that produced the results in the studies you have read about. And if your brand has failed an independent potency test, even the number on the label may not be what is in the capsule.
There are better options on the market. One of them is on this list.